← All diseases
Infectious diseases
Drug-resistant tuberculosis
Do you want to receive a message when there is new research on Drug-resistant tuberculosis? This is possible with an account. Create a free account or log in.
Automatically tracked from PubMed and ClinicalTrials.gov, newest on top. Nothing ever disappears here: what you keep in your favorites remains findable. · RSS feed of this disease · only the strongest evidence
Read in plain language what each study is about? With Premium, above each publication appears one sentence explaining what was investigated — and you receive a notification as soon as new research on Drug-resistant tuberculosis becomes available. View what Premium costs.
Publications and studies (1457)
- Recurrent complex spinal tuberculosis accompanied by sinus tract formation: causes of recurrence and clinical treatments. (2018/05/02) ♡
- Should all suspected tuberculosis cases in high income countries be tested with GeneXpert? (2018/05/01) ♡
- Analysis of tuberculosis case report in Hyderabad district of Telangana state. (2018/05/01) ♡
- Epidemiological profile of multidrug-resistant tuberculosis patients in Gorakhpur Division, Uttar Pradesh, India. (2018/05/01) ♡
- High use of private providers for first healthcare seeking by drug-resistant tuberculosis patients: a cross-sectional study in Yangon, Myanmar. (2018/04/11) ♡
- Cyclophostin and Cyclipostins analogues, new promising molecules to treat mycobacterial-related diseases. (2018/04/01) ♡
- Lipase-catalyzed kinetic resolution of novel antitubercular benzoxazole derivatives. (2018/04/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Novel compounds targeting InhA for TB therapy. (2018/04/01) ♡
- A selective and sensitive high performance liquid chromatography assay for the determination of cycloserine in human plasma. (2018/04/01) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Factors predicting treatment success in multi-drug resistant tuberculosis patients treated under programmatic conditions. (2018/04/01) ♡
- The Discovery of an Iridium(III) Dimer Complex as a Potent Antibacterial Agent against Non-Replicating Mycobacterium smegmatis. (2018/03/09) ♡
- Household contact non-attendance of clinical evaluation for tuberculosis: a pilot study in a high burden district in South Africa. (2018/03/05) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Team approach to manage difficult-to-treat TB cases: Experiences in Europe and beyond. (2018/03/01) ♡
- Evaluation of Loopamp™MTBC detection kit for diagnosis of pulmonary tuberculosis at a peripheral laboratory in a high burden setting. (2018/03/01) ♡
- Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis. (2018/03/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Triclosan and its derivatives as antimycobacterial active agents. (2018/03/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Challenges of using new and repurposed drugs for the treatment of multidrug-resistant tuberculosis in children. (2018/03/01) ♡
- Genotypic characterization of pyrazinamide resistance in Mycobacterium tuberculosis isolated from Lusaka, Zambia. (2018/03/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Trends in the discovery of new drugs for Mycobacterium tuberculosis therapy with a glance at resistance. (2018/03/01) ♡
- Drug resistant Skeletal Tuberculosis in a tertiary care centre in South India. (2018/03/01) ♡
- Aspartate-β-semialdeyhyde dehydrogenase as a potential therapeutic target of Mycobacterium tuberculosis H37Rv: Evidence from in silico elementary mode analysis of biological network model. (2018/03/01) ♡
- Reversed isoniazids: Design, synthesis and evaluation against Mycobacterium tuberculosis. (2018/02/15) ♡
- Molecular drug resistance profiles of Mycobacterium tuberculosis from sputum specimens using ion semiconductor sequencing. (2018/02/01) ♡
- Multidrug-resistant tuberculosis (MDR-TB) in a black African carceral area: Experience of Mali. (2018/02/01) ♡
- Human mesenchymal stromal cell therapy for damaged cochlea repair in nod-scid mice deafened with kanamycin. (2018/02/01) ♡
- Investigation of a cluster of multi-drug resistant tuberculosis in a high-rise apartment block in Singapore. (2018/02/01) ♡
- Corrigendum to 'Drug-resistant tuberculosis viewed from bacterial and host genomes' [International Journal of Antimicrobial Agents (2016) 353-360]. (2018/02/01) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Case Report: Carbapenemase-Producing Enterobacteriaceae in an Asylum Seeker with Multidrug-Resistant Tuberculosis. (2018/02/01) ♡
- Associations between Mycobacterium tuberculosis Beijing genotype and drug resistance to four first-line drugs: a survey in China. (2018/02/01) ♡
- The frequently occurring components of essential oils beta elemene and R-limonene alter expression of dprE1 and clgR genes of Mycobacterium tuberculosis H37Ra. (2018/02/01) ♡
- Characteristics of Mycobacterium Tuberculosis Positive Patients Screened for Drug-Resistant Tuberculosis at a Tertiary Health Facility in Lagos, Nigeria. (2018/02/01) ♡
- Anti-tubercular activity of a natural stilbene and its synthetic derivatives. (2018/02/01) ♡
- 1,3,5-triazaspiro[5.5]undeca-2,4-dienes as selective Mycobacterium tuberculosis dihydrofolate reductase inhibitors with potent whole cell activity. (2018/01/20) ♡
- Isolation, Identification, and Characterization of a New Highly Pathogenic Field Isolate of Mycobacterium avium spp. avium. (2018/01/15) ♡
- Human Immunodeficiency Virus-1 Drug Resistance Patterns Among Adult Patients Failing Second-Line Protease Inhibitor-Containing Regimens in Namibia, 2010-2015. (2018/01/12) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Isoniazid and rifampicin heteroresistant Mycobacterium tuberculosis isolated from tuberculous meningitis patients in India. (2018/01/01) ♡
- Systematic reviewiAll research on one question is searched according to fixed rules and compared side by side, so that no studies with poor outcomes are missed. Research on tuberculosis in tribal areas in India: A systematic review. (2018/01/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Targeting bacterial energetics to produce new antimicrobials. (2018/01/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Acquaintance to Artificial Neural Networks and use of artificial intelligence as a diagnostic tool for tuberculosis: A review. (2018/01/01) ♡
- Modeling the structural origins of drug resistance to isoniazid via key mutations in Mycobacterium tuberculosis catalase-peroxidase, KatG. (2018/01/01) ♡
- Major genotype families and epidemic clones of Mycobacterium tuberculosis in Omsk region, Western Siberia, Russia, marked by a high burden of tuberculosis-HIV coinfection. (2018/01/01) ♡
- Mechanisms of resistance to delamanid, a drug for Mycobacterium tuberculosis. (2018/01/01) ♡
- Polymorphisms in Rv3806c (ubiA) and the upstream region of embA in relation to ethambutol resistance in clinical isolates of Mycobacterium tuberculosis from North India. (2018/01/01) ♡
- Screening of antitubercular compound library identifies novel ATP synthase inhibitors of Mycobacterium tuberculosis. (2018/01/01) ♡
- A comparison of Rv0559c and Rv0560c expression in drug-resistant Mycobacterium tuberculosis in response to first-line antituberculosis drugs. (2018/01/01) ♡
- I3-Ag85 effect on phthiodiolone dimycocerosate synthesis. (2018/01/01) ♡
- The 7-phenyl benzoxaborole series is active against Mycobacterium tuberculosis. (2018/01/01) ♡
- Social support a key factor for adherence to multidrug-resistant tuberculosis treatment. (2018/01/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Vitamin C: A Natural Inhibitor of Cell Wall Functions and Stress Response in Mycobacteria. (2018/01/01) ♡
- Laboratory or animal researchiNo research in humans yet. Promising in a test tube or in mice unfortunately means nothing for patients. Acetate Kinase (AcK) is Essential for Microbial Growth and Betel-derived Compounds Potentially Target AcK, PhoP and MDR Proteins in M. tuberculosis, V. cholerae and Pathogenic E. coli: An in silico and in vitro Study. (2018/01/01) ♡
codex.care does not provide medical advice. Always discuss symptoms, medication, and treatment choices with your own healthcare provider.